Pulsenmore Ltd. — Form 6-K
Reporting date: October 13, 2026. The filing reports an event by the Israeli foreign private issuer and furnishes a press release as Exhibit 99.1.
Business context and material development
The press release is titled “Pulsenmore Strengthens U.S. Commercial Leadership, Appoints Med-Tech Veteran David Woods as Chief Commercial Officer.” The supplied filing text does not include the press release itself or further details about the appointment.
Financial results and outlook
The filing text provides no revenue, profit, cash flow, margin, debt, liquidity, guidance, or other financial metrics. It contains no stated outlook, risk discussion, or contingencies.
Key facts to verify
- Review Exhibit 99.1 for David Woods’s background, appointment terms, and Pulsenmore’s stated U.S. commercial plans.
- Check subsequent filings for any financial or operational updates related to the appointment.
- The first three paragraphs of Exhibit 99.1 are incorporated by reference into Pulsenmore’s Form S-8 registration statement; those paragraphs are not included in the supplied text.